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ABSTRACT 
The chlorovirus Paramecium bursaria 
chlorella virus 1 (PBCV-1) is a large dsDNA 
virus that infects the microalga Chlorella 
variabilis NC64A. Unlike most other viruses, 
PBCV-1 encodes most, if not all, of the 
machinery required to glycosylate its major 
capsid protein (MCP). The structures of the four 
N-linked glycans from the PBCV-1 MCP consist 
of nonasaccharides, and similar glycans are not 
found elsewhere in the three domains of life. 
Here, we identified the roles of three virus-
encoded glycosyltransferases (GTs) that have 
four distinct GT activities in glycan synthesis. 
Two of the three GTs were previously annotated 
as GTs but the third GT was identified in this 
study. We determined the GT functions by 
comparing the wild-type glycan structures from 
PBCV-1 with those from a set of PBCV-1 
spontaneous GT genes mutants resulting in 
antigenic variants having truncated glycan 
structures. According to our working model, the 
virus gene a064r encodes a GT with three 
domains: domain 1 has a -L-
rhamnosyltransferase activity, domain 2 has an 
-L-rhamnosyltransferase activity and domain 3 
is a methyltransferase that decorates two 
positions in the terminal -L-rhamnose (Rha) 
unit. The a075l gene encodes a -
xylosyltransferase that attaches the distal D-
xylose (Xyl) unit to the L-fucose (Fuc) that is part 
of the conserved N-glycan core region. Lastly, 
gene a071r encodes a GT that is involved in the 
attachment of a semiconserved element, -D-
Rha, to the same L-Fuc in the core region. Our 
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results uncover GT activities that assemble four 
of the nine residues of the PBCV-1 MCP N-
glycans. 
 
 
Structural proteins of many viruses, such 
as rhabdoviruses, herpesviruses, poxviruses and 
paramyxoviruses, are glycosylated. Most virus 
glycoproteins are N-linked to Asn via N-
acetylglucosamine (GlcNAc), while less frequent 
O-linked glycosylation also occurs (1). The 
majority of the viruses studied to date use host-
encoded glycosyltransferases (GTs) and 
glycosidases located in the endoplasmic 
reticulum (ER) and Golgi apparatus to add and 
remove N-linked sugar residues from virus 
glycoproteins either co-translationally or shortly 
after translation of the protein (2-6). Post-
translational glycosylation can aid in protein 
folding, protein stability, progression in the 
secretory pathway and host-virus interactions.  
One group of viruses that differs from the 
above scenario is the plaque-forming 
Chloroviruses (family Phycodnaviridae) that 
infect certain isolates of chlorella-like green algae 
(7). The viruses are divided into four groups 
depending on the algal host infected: 
chloroviruses that infect Chlorella variabilis 
NC64A are referred to as NC64A viruses, those 
that infect Chlorella variabilis Syngen 2-3 are 
referred to as Osy viruses, those that infect 
Chlorella heliozoae SAG 3.83 are referred to as 
SAG viruses and those that infect Micractinium 
conductrix Pbi are referred to as Pbi viruses. The 
prototype chlorovirus Paramecium bursaria 
chlorella virus (PBCV-1) is an NC64A virus (8) 
and its 330 kb genome is predicted to encode 416 
proteins (9). The major capsid protein (MCP or 
Vp54) is coded by the gene a430l, and its gene 
product has a predicted molecular weight of 
48,165 Da, which increases to 53,790 Da due to 
N-glycosylation at four positions (10, 11).  
The predominant glycoform of the four 
PBCV-1 N-glycans is a nonasaccharide (Fig. 1 
WT) (11) with several unusual structural features 
including: i) it is not linked to the typical Asn-X-
(Thr/Ser) sequon; ii) it is highly branched; iii) -
glucose (Glc) forms the N-linkage with Asn; iv) 
fucose (Fuc) is substituted at all available 
positions; and v) there are two rhamnose (Rha) 
residues with opposite configurations plus an L-
Rha capped with two O-methyl groups. Two 
monosaccharides, arabinose (Ara) and mannose 
(Man), occur as non-stoichiometric substituents 
resulting in the existence of four glycoforms (Fig. 
1). Currently, structures of this type are unknown 
elsewhere in the three domains of life. 
The discovery of these glycans has 
prompted our interest in viral glyco-related 
genes. In this regard, 17 of the PBCV-1 genes 
encode enzymes that manipulate sugars at 
different levels (12) with six of them annotated as 
encoding putative GTs: a064r (638 amino acids), 
a111/114r (860 aa), a219/222/226r (677 aa), 
a473l (517 aa), a546l (396 aa), and a075l (280 
aa) (Table S1). In addition, a098r encodes a 
functional hyaluronate synthase (13).  
The genes encoding these GTs are 
scattered throughout the genome of the virus and 
PSORT predicted that most of these proteins are 
soluble and located in the cytoplasm; a473l and 
a219/222/226r are predicted to encode GTs with 
six and nine transmembrane domains, 
respectively, while the ngLOC program predicts 
that A075L is located in the chloroplast, but only 
at a 15% confidence level. 
Thus, PBCV-1 encodes six GTs, a small 
number when compared to the complexity of its 
N-glycans. One solution to this paradox is that 
one or more of the six GTs might have multiple 
functional domains, making this restricted 
repertoire of enzymes sufficient to synthesize 
these structures. A second possibility is that some 
other virus genes encode enzymes that do not 
match GTs in the databases and so are overlooked 
during the searches. Finally, we cannot exclude 
the possibility that a host-encoded GT(s) could be 
involved in the glycosylation process. 
The protein encoded by gene a064r is of 
special interest. This protein is coded by PBCV-
1 but not by any other chlorovirus where the 
glycan structure is known (12), suggesting that 
the a064r gene product is involved in the 
synthesis of a structural motif of the N-glycan not 
shared with the other chloroviruses (14-16). In 
addition, several spontaneous mutants (or 
antigenic variants) in a064r have been isolated 
and their MCPs migrate faster on SDS-PAGE 
compared to the MCP of PBCV-1, suggesting 
that the glycan portion of the capsid protein is 
altered. 
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These PBCV-1 spontaneous mutants are 
divided into six antigenic classes, each denoted 
with a letter, based on their differential reaction 
to five different polyclonal antibodies (12, 17). 
Each class reacts specifically with one polyclonal 
antibody preparation, except Class E, which 
cross-reacts with Class A and B polyclonal 
antibodies, suggesting that the phenotype of 
Class E variants share some of the structural 
features of the other two variants. Notably, all six 
antigenic classes, except C, have a mutation in the 
a064r gene (Table 1, Fig. 1).  
For the reasons cited above and elsewhere 
(12, 18), we hypothesize that the machinery for 
PBCV-1 glycosylation is encoded primarily, if 
not totally, by the virus. Furthermore, 
glycosylation of the PBCV-1 MCP occurs in the 
cytoplasm. The current study addresses two 
issues related to PBCV-1 glycosylation. First, the 
structures of the glycans attached to five PBCV-
1 antigenic variant MCPs are described. Second, 
using genetic and glycan structure evidence, we 
identify four of the putative GT activities 
involved in the synthesis of the glycan(s).  
 
Results 
Glycan structures from representatives of the 
antigenic variants 
The structures of the glycans from five 
different classes (Class E variants were not 
included in this study) were determined by 
combining chemical (via GC-MS of the 
appropriate derivatives) and NMR analyses, 
using the consolidated approach developed for 
PBCV-1 and the other chloroviruses (11, 14-16). 
The 1H NMR spectrum of each variant (Fig. 2) 
differed from that of wild-type virus PBCV-1, 
supporting our hypothesis that the glycans were 
different. Accordingly, the features of each 
antigenic class will be described in increasing 
order of the structural complexity of the glycans. 
By convention, the monosaccharide residues 
identified in each oligosaccharide are labeled 
with the same (or a similar) letter used for the 
analog unit of the glycan of the wild-type (WT) 
virus PBCV-1 (Fig. 1 and Figs in the supporting 
material). Unless mentioned otherwise, we have 
focused on the major glycan structure of each of 
the variants. In some cases, minor structures 
made up less than 5-10% of the total sample.  
 
Class D: structure of the glycan of the antigenic 
variant P1L6 
This virus is the most difficult to handle in 
laboratory conditions because it is unstable and 
tends to degrade during normal purification 
procedures. This intrinsic fragility of the viral 
particles hindered the obtaining of large amounts 
of biomass. Thus, to avoid further losses during 
chromatographic purification, the glycopeptide 
mixture was studied directly omitting this 
purification step.  
Inspection of the 1H NMR spectrum of the 
P1L6 glycan (Fig. 2, Fig. S1) showed two 
anomeric signals at 5.61 and 5.28 ppm along with 
a set of small signals at ca. 5.0 ppm, while the 
other regions were crowded with signals from 
peptides resulting from capsid protein digestion. 
The structure of the glycan was determined 
by combining the chemical data with the analysis 
of the Heteronuclear Single Quantum Correlation 
(HSQC) spectrum. GC-MS analysis of the 
partially methylated and acetylated alditol 
(PMAA) derivatives (not shown) indicated that 
the sample contained a 2-linked Fuc, a terminal 
Gal, a terminal Xyl, and a 3,4-linked Glc. The 
HSQC spectrum (Fig. S1, Table S2) had four 
anomeric resonances, and the overlap with the 
spectrum of the PBCV-1 glycan, used as a 
reference, permitted the identification of three of 
the four residues. As for H (3,4-substitued N-
linked -Glc), E (terminal -Gal) and N (terminal 
-Xyl), the 13C NMR chemical shifts were almost 
identical to that of the reference glycan, with only 
minor variations in the 1H NMR chemical shifts. 
The remaining carbon resonances were assigned 
to Fuc A, whose values differed from those of the 
reference glycoside (19) due to glycosylation at 
C-2. Thus, the N-linked glycan of P1L6 is a 
tetrasaccharide, significantly truncated compared 
to that of WT PBCV-1. It contained all the units 
of the chloroviruses N-glycans present in the 
conserved core region except the Xyl attached to 
Fuc, referred to as the distal Xyl (14). 
 
Class C: structure of the antigenic variants E11 
and E1L3 
The identity of the E1L3 and E11 glycans 
was deduced from the similarities between the 
anomeric region of their proton spectra (Fig. 
S2A) and by the coincidence of their HSCQ 
spectra (Figs. S2B, S3). In addition, when 
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compared to P1L6 HSQC (Fig. S1), both E11 and 
E1L3 had one additional anomeric signal at 5.03 
ppm.  
As for E1L3, comparison of its HSQC 
spectrum with those of PBCV-1 glycopeptides, 
permitted the ready identification of several 
monosaccharide units (Table S3): the N-linked 
Glc H, the proximal Xyl N, and the Gal E. The 
anomeric proton at 5.03 ppm was identified by 
analyzing the other 2D NMR spectra including 
correlation spectroscopy (COSY), total 
correlation spectroscopy (TOCSY) and 
transverse rotating frame Overhauser effect 
spectroscopy (T-ROESY). These data revealed 
that this resonance arose from a D-Rha unit linked 
at O-3 of the Fuc unit A. Unlike the wild-type 
glycan, this D-Rha was not further substituted 
with the terminal Man G; therefore, it was 
labelled F’ (and not F). Thus, E1L3 and E11 
glycans are extended derivatives of P1L6 with the 
D-Rha unit. Accordingly, the Fuc residue was 
substituted at both O-2 and O-3 positions, in 
agreement with the GC-MS linkage analysis of 
this fraction (Fig. S2C). 
 
Class B: structure of the glycan of antigenic 
variants EPA1 and EPA2  
The 1H NMR (Fig. S4A) and HSQC (EPA2 
reported as an example in Fig S4B) spectra of 
EPA1 and EPA2 glycopeptides were almost 
identical, and both displayed two anomeric 
signals at 4.5-4.4 ppm, the region that in the 
PBCV-1 wild-type glycan contains the two -Xyl 
units M and N. 
The units with anomeric signals at 5.63, 
5.23, 5.04, 5.01 and 4.42 ppm were readily 
attributed to the Fuc A, Gal E, D-Rha F’, Glc H 
and to the proximal Xyl N, respectively, by 
comparison with PBCV-1 glycan data. Notably, 
the proton and carbon chemical shifts of Fuc A 
(Table S4) indicated that this Fuc was substituted 
at all the positions available, while D-Rha F’ was 
not glycosylated.  
Hence, NMR analysis focused on the 
additional anomeric signal at 4.46 ppm. Studying 
the connectivities from all the 2D NMR spectra 
revealed that this signal belonged to a Xyl unit, 
connected to O-4 of A as in the PBCV-1 WT 
glycan, but not further substituted. Accordingly, 
this Xyl was labeled M’. Overall, the NMR data 
showed that the structure of the glycans of the 
antigenic class B, EPA1 and EPA2, consisted of 
the conserved core region characteristic of all the 
chloroviruses N-glycans described to date (14-
16) plus the semi-conserved element, the D-Rha 
unit F’ (Fig. 1). 
 
Class A: structure of the glycans of antigenic 
variants P91, P9L1 and P9L10.  
The glycopeptides from the three variants 
of Class A shared a similar pattern of signals in 
the anomeric region of the 1H NMR spectra, 
although some marginal variations of their 
relative intensities were noted (Fig. S5A). 
Compared to Class B, the anomeric region of the 
1H NMR spectra of class A contained several 
additional signals, and the structural elucidation 
of these glycopeptides was performed by the 
combined analysis of the 2D NMR spectra (Figs. 
S5-7 and Tables S5-6) as discussed for the other 
variants, and detailed in the Supporting 
Information. 
Indeed, P9L10 produces a family of four 
glycopeptides, named P9L10A-D (Fig. S6), with 
the distal Xyl M (or M”, see discussion in 
Supporting Information) further elongated with 
the -L-Rha unit. These four glycans differed in 
the non-stoichiometric presence of two residues, 
Man and Ara, as shown in Fig. S6. 
As for the P9L1 glycopeptides, the HSQC 
spectrum was almost superimposable on that of 
P9L10. Some variations occurred for the 
intensities of some signals as deduced by 
comparing their proton spectra (Fig S5). In P9L1, 
the intensities of E and E’ were comparable 
suggesting that D-Rha was much less substituted 
with Man compared to P9L10 glycopeptides. 
Densities reporting the Ara (D unit) were not 
detected, indicating that this unit was absent or 
below the detection limit. Accordingly, P9L1 
produced two main glycopeptides, analogues to 
P9L10A and P9L10B (Fig. S6). 
As for the glycopeptides of P91 (Fig. S7, 
Table S6), most of the densities of its HSQC 
spectrum (Fig. S7A, B) overlapped with those of 
the P9L1 and P9L10 variants. Like P9L1, P91 
variant lacks the Ara substitution to -L-Rha, and 
produced two oligosaccharides equivalent to 
P9L10A and P9L10B, as confirmed by analyzing 
the homonuclear spectra (T-ROESY in Fig. S7C 
and TOCSY in Fig. S7D). Importantly, these 
spectra enabled the assignment of densities that 
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escaped the HSQC detection due to the low 
amount of the sample, including C-4 or C-5 of 
M’’ (the putative position of these densities is 
enclosed in a dotted circle in Fig. S7B). 
The P91 HSQC spectrum contained some 
additional signals, including a methyl group at 
1H/13C 3.56/62.4 ppm (Fig. S7A) and an anomeric 
proton at 1H/13C 4.75/103.4 ppm (Fig. S7B). 
NMR analysis of this new residue determined 
that it was a -L-Rha, labelled as I”, that differed 
from I and I’ because it was methylated at O-2 
(Table S6). Methylation at O-2 did not induce 
relevant variations in the chemical shift values of 
all the other monosaccharides of the glycan, 
except for H-4/C-4 values (1H/13C 3.71/80.5 ppm) 
of the Xyl unit to which it was attached, named 
M’”. For this new oligosaccharide (named P91, 
Fig. S7) it was not possible to confirm if the D-
Rha unit F was further elongated with Man G, 
although this situation is the most plausible given 
the abundance of this residue, similar to that of 
Gal or Glc, as visible in the GC-MS profile of the 
monosaccharide analysis (Fig. S5C). GC-MS 
analysis also confirmed the presence of the 
rhamnose unit methylated at O-2, and detected a 
tiny amount of arabinose, that escaped the NMR 
analysis due to its low abundance.  
 
Class F: structure of the glycan of antigenic 
variant CME6  
Virus CME6 is the only variant isolated for 
antigenic class F. Its proton and HSQC spectra 
(Figs. 2 and S8) contained an additional anomeric 
signal at 1H/13C 5.04/102.7 ppm (Fig. S8) when 
compared to those of the P9L10 variant. 
Comparison of the CME6 HSQC spectrum with 
that of PBCV-1 readily identified most of the 
residues, namely A, D-H, M and N, for which the 
positions of all the proton and carbon resonances 
were almost identical. Of note, units E’ or F’ 
described in class A variants were absent or 
below the NMR detection limit indicating that D-
Rha was fully substituted with Man. Minor 
differences were found for the chemical shifts of 
the residues I and L, the -L-Rha units 2- and 2,3-
linked, respectively.  
Analysis focused on the signal C at 1H/13C 
5.04/102.7 ppm, which had a weak H-1/H-2 
correlation in the COSY spectrum (not shown), 
while TOCSY spectrum read from H-2 (4.09 
ppm) position identified the position of all the 
other protons of the unit, with H-6 at 1.26 ppm. 
Thus, C was a Rha, and carbon chemical shift 
values (Table S7) determined that it was -
configured at the anomeric center and not further 
substituted. HMBC and T-ROESY spectra 
showed that it was attached to O-2 of I, as in the 
wild type virus, with the only difference that none 
of its positions were further decorated with a 
methyl group (Fig. 1). 
As for other minor anomeric signals, it was 
possible to assign only that at 1H/13C 5.15/101.8 
ppm (Fig. S8), labeled B. It was an -Rha, that 
differed from the most intense C because it was 
attached to O-2 of L, the -Rha unit with D at O-
3.  
Collectively, these data indicated that 
CME6 produces a mixture of two N-glycans 
(Figs. 1 and S8), identical to those described for 
WT PBCV-1 with the only difference being that 
the -L-Rha unit was not methylated. 
 
Predicted PBCV-1 encoded genes involved in the 
synthesis of its glycan 
Based on the discovery that the structures 
of the glycans from the five antigenic classes 
were truncated versions of the glycan from the 
WT PBCV-1 MCP and knowing that PBCV-1 
already had several genes annotated as GTs (12, 
Table S1), allowed us to predict the function of 
some of them. These predictions were aided by 
the fact that the complete genomes of a few 
representatives of each of the four groups of 
chloroviruses mentioned in the introduction 
(NC64A, Osy, SAG, and Pbi viruses) have been 
sequenced (7, 15) and the structures of the 
glycan(s) attached to their MCPs have been 
determined (14-16). The basic glycan core 
structure is conserved in all of these viruses 
(outlined in Fig. 1). Additional sugar decorations 
occur on their respective core N-glycan structures 
and present a molecular signature for each 
chlorovirus. Therefore, knowledge of the glycan 
structures and the presence/absence of genes 
from the various groups of chloroviruses 
contributed to our prediction of the role for two 
of the PBCV-1 GTs. The features of each putative 
GT are hereafter discussed in light of the 
structural information of the glycans determined 
in this study. 
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Class D mutants and the role of A111/114R in the 
core glycan assembly/attachment 
The four antigenic mutants in Class D 
(P1L2, P1L3, P1L6 and P1L10) contain large 
genomic deletions in similar locations that range 
in size from 27.2 kb to 38.6 kb (genome 
nucleotide locations: 12,407 to 39,576; 5,238 to 
42,695; 2,190 to 40,797 and 7,698 to 39,722, 
respectively), or collectively from genes a014r 
through a078r (20). All of the chloroviruses (14-
16), as well as four of the five PBCV-1 antigenic 
classes, have the conserved glycan core structure 
composed of five monosaccharides (one unit of 
D-Glc, D-Gal and L-Fuc, and two units of D-Xyl) 
attached to the MCP (Fig. 1), plus D-Rha, the 
semiconserved unit attached to Fuc. 
Class D mutants are the only class with a 
reduced core glycan structure (Fig. 1) and this 
finding supported two conclusions: i) the core 
structure is coded by a gene (or genes) located 
outside of the collective region of the four large 
deletion mutants; ii) the genes encoding the 
attachment of the distal D-Xyl, the fifth unit of the 
conserved core region, and the D-Rha, the 
semiconserved unit of the core glycan, probably 
lie in the region between a014r and a078r.  
Accordingly, these two observations 
suggest that the protein A111/114R 
(NP_048459.2) is involved in the initiation 
and/or attachment of four of the monosaccharides 
in the conserved core glycan. Further evidence to 
support this inference is that this gene and the 
corresponding tetrasaccharide are present in all 
the chloroviruses analyzed to date. Because the 
chlorovirus core glycan is unique in nature, we 
assume it must be at least partially, if not fully, 
assembled/attached to the MCP by either a single 
large viral protein or several smaller viral 
proteins that are common to all the chloroviruses. 
In PBCV-1, gene a111/114r is the only annotated 
orthologous GT gene found outside of the regions 
of the large deletion mutants described above and 
which is present in all the other chloroviruses. In 
addition, no MCP glycans smaller than the four-
sugar units have been found in any of the 
chloroviruses (14-16) or in the PBCV-1 antigenic 
variants (this manuscript).  
The a111/114r gene, not including the 
promoter region, consists of 2583 nts, which is 
longer than any of the other annotated PBCV-1 
GT genes. This gene encodes protein A111/114R, 
which consists of 860 amino acids organized into 
at least three domains; the second domain has 
been annotated as a GT (9). 
Because of the size of the a111/114r gene, 
it is highly likely that mutations have occurred in 
the gene over time, but such mutations are 
probably lethal because no variant has been 
isolated. The working model is that a mutation in 
the a111/114r gene, and in the orthologous genes 
from all of the chloroviruses, would result in the 
absence of a glycan core attached to the MCP, 
leading to the loss of a viable virus. This leads to 
the conclusion that the unique four-sugar 
structure is the minimal glycan required for 
chlorovirus survival, although the way it 
contributes to the viability of the virus is still 
unclear. Certainly, the hydrophilic nature of the 
glycans would help the virus to remain soluble, 
and thus infective, in an aquatic environment. 
Furthermore, as noted above, Class D variants are 
unstable in the laboratory, suggesting that the 
glycans may be important for MCP folding 
and/or for the correct assemblage of the capsid. 
Thus, all available evidence supports the 
conclusion that A111/114R plays a key role in the 
assemblage of part or all of the conserved core 
oligosaccharide.  
 
Class C mutants and the role of A071R  
The glycans of the Class C mutants (Fig. 1) 
differ from those of Class D because they have a 
D-Rha attached to L-Fuc; however, like the Class 
D mutants, the Class C mutants lack the distal D-
Xyl and its attached sugars. The gene encoding 
the enzyme involved in the attachment of D-Rha 
to L-Fuc is located somewhere in the region 
between genes a005r through a077l because the 
Class D antigenic mutant P1L6, which lacks the 
D-Rha, has no mutations in its genome other than 
the large deletion that extends from genes a005r 
through a077l. Therefore, the gene that encodes 
the protein that performs this task must: i) lie 
between genes a005r and a077l, ii) be found in 
other NC64A viruses and OsyNE5, all of which 
have a D-Rha attached to the L-Fuc, and iii) must 
be absent in SAG and Pbi viruses because they 
lack a D-Rha in that position. The only PBCV-1 
gene that fits all of these requirements is a071r. 
The protein encoded by this gene, A071R 
(NP_048419.1), is of sufficient size (354 aa) to be 
a GT although it has not been annotated as such. 
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However, A071R does have sequence similar to 
A064R domain 2, which also has not been 
annotated as a GT but for which there is strong 
evidence that it is a rhamnosyl GT (discussed 
below).  
 
Class C mutants and the role of A075L 
Class C antigenic variants also have 
mutations that prevent the addition of the distal 
D-Xyl, which is necessary before the addition of 
the two L-Rha units. As noted above in the 
discussion of the Class D large deletion mutants, 
the protein that attaches the distal D-Xyl to the L-
Fuc must be encoded by a gene that lies between 
the genes a014r and a078l. The genetic evidence 
supports the hypothesis that the protein A075L 
(NP_048423.1) attaches D-Xyl to L-Fuc. This 
protein was previously annotated as an exostosin 
(Pfam database code PF03016.8), classified 
within the GT47 family. Six Class C antigenic 
mutants were genomically sequenced (E1L1, 
E1L2, E1L3, E1L4, P41 and E11), and all six 
have mutations in the a075l gene, but none of 
them shared mutations in any of the other genes 
that putatively encode GTs. The mutations in the 
gene a075l were of three types: i) frameshift 
mutations that cause premature termination of the 
synthesis of the A075L protein; ii) nonsense 
mutations that lead to premature termination of 
A075L protein synthesis; and iii) in one case a 
missense mutation in the initiator codon that 
results in a failure to initiate A075L protein 
synthesis. One of the Class C mutants, E11, is of 
particular interest. E11 is derived from the Class 
B antigenic mutant EPA-1, but the mutation 
common with EPA-1 became masked when E11 
acquired a second mutation, located in gene 
a075l, which prevents the addition of the distal D-
Xyl, the feature that distinguishes the Class C 
mutants from those in Class B.  
Additional evidence that supports the role 
of A075L comes from seven other chlorovirus 
species whose MCP glycan structures have been 
determined (14-16). Even though these seven 
chloroviruses infect four different algal hosts, all 
of them have the same glycan core structure and 
the same distal D-Xyl attached to the L-Fuc, as 
does the wild type PBCV-1. These seven 
chloroviruses all encode orthologs of the PBCV-
1 A075L protein. 
 
Class B mutants and the role of A064R domain 1 
(A064R-D1) 
Class B antigenic variants lack the terminal 
two L-Rha moieties (Fig. 1) but have the terminal 
D-Xyl because they all have a functional a075l 
gene; however, they have mutations that prevent 
further elongation of the oligosaccharide chain. 
Three Class B antigenic variants have been 
genomically sequenced (EPA-1, EPA-2, and 
P31), and all have mutations in the a064r gene, 
which encodes the protein A064R 
(NP_048412.1). This protein consists of 638 
amino acids that are organized into at least three 
functional domains of approximately 200 amino 
acids each (Fig. 1). More specifically, all three 
Class B antigenic variants have mutations in the 
region of the a064r gene, that encodes domain 1 
of A064R.  
Previous studies annotated this domain as 
a “fringe class” GT and hypothesized that the 
DXD motif coordinated the phosphate of the 
nucleotide sugar, presumably UDP-Glc, and a 
divalent cation, Mn2+ (21, 22). The specificity of 
this domain could not be inferred at that time 
because the structure(s) of the N-glycans were 
unknown, preventing any hypothesis about the 
nature of the possible acceptor and donor 
substrates.  
Understanding the function of domain 1 
was inferred by comparing the N-glycans of 
Class B with those of Class A variants. These two 
sets of N-glycans (Fig. 1) differ in the presence of 
the -L-Rha unit I (or L), supporting the 
hypothesis that the first domain of A064R 
encodes a -L-rhamnosyltransferase that adds 
this monosaccharide to O-4 of a Xyl unit M.  
As a possible nucleotide donor, we 
hypothesize that A064R-D1 uses UDP-L-
rhamnose as substrate, while most prokaryotic 
enzymes recognize the dTDP-bound sugar. This 
difference can be explained by the fact that, in 
contrast to GDP-L-fucose or GDP-D-Rha that can 
be produced by virus derived enzymes (23), a 
UDP-L-rhamnose biosynthetic pathway is not 
encoded by the PBCV-1 genome. Thus, the 
nucleotide activated L-rhamnose is presumably 
synthesized by the chlorella host, using a typical 
plant UDP-L-rhamnose biosynthetic pathway 
(24). 
This hypothesis is corroborated by both 
docking studies (see below) and by biochemical 
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evidence that A064R domain 1 has this predicted 
activity.1 
 
Class A mutants and the role of A064R domain 2 
Class A antigenic variants only lack the 
terminal -L-Rha. Three variants of this antigenic 
class have been genomically sequenced (P91, 
EPA-11 and P9L1), and all of them lack 
mutations in domain 1 of a064r, but all three have 
mutations in domain 2 of this gene (Fig. 1), which 
encodes a bacterial-derived protein of unknown 
function. Furthermore, none of these three 
variants has mutations in the gene that encodes 
A075L. Thus, these three members of class A are 
able to add the terminal D-Xyl and the -L-Rha to 
the core glycan (Fig. 1). Two of the three mutants, 
P9L1 and EPA-11, have nonsense mutations 
(point mutations that become stop codons) that 
lead to premature termination of translation. The 
third mutant, P91, has a 27-nucleotide insertion 
in the region of a064r that encodes domain 2. In 
addition, the a064r gene of another class A 
mutant, P9L10, was amplified by PCR and 
sequenced. P9L10 acquired a nonsense mutation 
in a064r that results in premature termination of 
A064R near the N-terminus of domain 2; 
consequently, the functions of both domain 2 and 
3 are lost.  
In summary, all of the class A variants 
encode a functional domain 1 of A064R but are 
unable to encode a functional domain 2. These 
results are consistent with the glycan structure 
results, which support the hypothesis that domain 
2 is involved in the attachment of the second Rha 
unit (C or B), the one with an  glycosidic 
linkage and placed at O-2 of the first L-Rha unit 
(I or L). For the reasons mentioned for A064R-
D1, our working hypothesis is that the second 
domain of A064R accepts UDP-L-Rha as donor. 
 
Class F mutant and the role of A064R domain 3 
The antigenic variant CME6, whose 
genome has been sequenced, is the only member 
of antigenic class F (Table 1). The CME6 a064r 
gene has a TC dinucleotide insertion at genome 
position 36,276, which leads to premature chain 
termination during translation of domain 3, while 
the first two domains are unaffected. 
Accordingly, the N-glycans of this variant 
                                                             
1 De Castro et al., work in progress 
contain all the sugars that comprise the wild-type 
glycan but lack the methyl groups at the O-2 and 
O-3 positions of the terminal Rha units C or B 
(Fig. 1). This finding confirms the role of the first 
two domains of A064R, namely the first domain 
attaches -L-Rha (I or L) to -Xyl M and domain 
2 attaches the last Rha unit (C or B) to the -L-
Rha. 
While PBCV-1 encodes numerous DNA 
methyltransferase genes, the only mutated 
methyltransferase gene in CME6 is in the region 
of gene a064r that encodes domain 3 (Fig. 1). The 
best hit in a BLAST search of the wild type amino 
acid sequence of domain 3 to the nucleotide 
database at NCBI was to 2’-O-
rhamnosylmethyltransferases. Indeed, when the 
rhamnosyl-methyltransferase from 
Mycobacterium smegmatis (25), was BLASTED 
against the PBCV-1 protein database, the only hit 
was to domain 3 of A064R (33% identity and 
49% positive). Consequently, when a064r is 
mutated in the third domain, the corresponding 
N-glycan is not methylated at either the O-2 or O-
3 positions, suggesting that this methyltransferase 
can perform a double methylation of the 
monosaccharide. However, we cannot exclude 
the possibility that domain 3 attaches only one 
methyl group and that a second 
methyltransferase, yet to be identified, is required 
to complete the full decoration of this Rha.  
The mutant P91, a Class A variant, 
provides additional support that domain 3 is a 
rhamnosyl-methyltransferase. In the case of P91, 
domain 3 of A064R is translated correctly 
because the 27-nucleotide insertion in the second 
domain of a064r maintains the correct reading 
frame during its translation. Analysis of the P91 
glycopeptide mixture detected a minor form with 
-L-Rha methylated at O-2 (I”, Fig. S7). Thus, 
domain 3 appears to be functional in P91, but it 
lacks its natural substrate because the -L-Rha 
unit C (or B) is not assembled at the end of the 
glycan (see PBCV-1 structure in Fig. 1 and P91 
glycan structure in Fig. S7) but there is a -L-Rha 
for which it may have a reduced affinity. 
 
Modeling of UDP-Rha into the catalytic domain 
1 of A064R  
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Based on the evidence collected in this 
study, A064R-D1 is predicted to use UDP-L-Rha 
as the activated donor to synthetize the -L-Rha-
(1,4)--D-Xyl linkage. In a previous study (22), 
this domain was cloned and crystallized and the 
authors tested several nucleotide sugars, but not 
UDP-L-Rha. The best affinity was found for 
UDP-Glc. Therefore, a molecular modeling 
approach was used to determine whether UDP-L-
Rha is an acceptable substrate for this GT.  
Docking methods are widely used to define 
or predict the binding mode of a small ligand to a 
receptor. Although these methods are efficient in 
discriminating between binders and non-binders, 
they are not particularly accurate and typically 
cannot discriminate between substrates that differ 
by less than one order of magnitude in affinity 
(26). This is the case for the possible Rha/Glc 
relative selectivity for A064R-D1. Subtle 
differences originate from contributions of 
hydrogen bonds and CH/ staking interactions. 
Thus, a molecular dynamics (MD) approach was 
used (27, 28). The structure deposited in the 
protein database (PDB accession number 2P72) 
contains UDP-Glc as substrate. Therefore, its 
behavior was compared to that computed for the 
UDP-L-Rha analogue.  
In the X-ray structure, the donor UDP-Glc 
is stabilized in the binding site by several 
hydrogen bonds and Mn2+-oxygen interactions. 
Specifically, upon ligand binding, the protein 
undergoes a major conformational change, which 
shifts Phe13 towards the uracil ring of UDP. Two 
hydrogen bonds between the Phe13 backbone 
atoms and the uracil ring are established. These 
same hydrogen bond interactions are established 
(compare Figs. 3A,D and 3B,E) in the model of 
A064R-D1 bound to UDP-L-Rha and kept 
throughout the entire simulation time (Fig. S9). 
Similarly, the hydrogen bond network described 
for the ribose moiety in the X-ray structure is also 
maintained during the whole MD simulation 
(Figs. 3B,E and S9). Specifically, the carbonyl 
oxygen of Gly11 interacts with the OH2 of ribose, 
while the NH of Ser79 is a hydrogen bond donor 
to O3 of ribose. The hydrogen bond between the 
carboxyl side chain of Asp78 and the OH3 of 
                                                             
2 De Castro, work in progress 
ribose is established only in the last 25 ns of the 
MD simulation (Fig. S9). 
It has previously been described that His54 
experiences a significant conformational change 
upon UDP-Glc binding (Fig. 3C), suggesting a 
key role for this residue as the required catalytic 
base (22). Along this line, the MD simulation of 
A064R-D1 with UDP-Rha clearly identifies a 
stacking interaction among the histidine electron 
cloud and the C-H moiety of the less polar face of 
Rha (Fig. 3F). This CH/ interaction is stable in 
all the MD simulations (Fig. S9). These findings 
are in full agreement with the previous hypothesis 
(22) about the role of N in His54, which 
stabilizes the partial positive charge that develops 
during the course of the reaction at the C1 atom. 
In fact, the C1-N distance is only 4.5 Å on 
average (Figs. 3F and S9). Finally, UDP-L-Rha is 
kept in the catalytic site by a polar network 
involving Arg57 and Pro149, which makes 
hydrogen bonds with OH4 of the sugar ring (Figs. 
3F and S9). 
Next, the free energy of binding for both 
UDP-L-Rha and UDP-Glc to A064R-D1 was 
estimated by MM/GBSA methods (25, 26). 
Interestingly, the computations predict that the 
binding free energy for the A064R-D1/UDP-L-
Rha complex is ca. 6 kcal/mol lower than that for 
the A064R-D1/UDP-Glc analogue (Table 2), in 
agreement with the prediction of the specificity of 
this GT, and our preliminary experimental 
results.2 Among the key components of the 
binding free energy, UDP-Glc displayed the 
largest electrostatic energy changes upon binding 
(EELE) and also showed the largest polar 
solvation energy (GSol). Thus, the computational 
analysis strongly suggests that the major factor 
favoring the binding of A064R-D1 for UDP-L-
Rha over UDP-Glc is the lower polar character of 
Rha with respect to Glc. These results are also in 
agreement with the low polarity of the A064R-D1 
binding site defined by Pro149, Phe148 and 
Tyr150, which perfectly fit with the methyl 
substituent of Rha through hydrophobic 
interactions. Furthermore, we investigated why 
the antigenic variant EPA-1 lacks the terminal L-
Rha moieties, by docking the A064R_S79L 
mutant with UDP-Rha substrate. The results of 
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the analysis show that the bulky side chain of the 
Leu79 entails the reorganization of the DXD 
motif, with a consequent loss of Mn2+ 
coordination and most of the essential 
interactions with the substrate. Specifically, 
although the hydrogen bonds between the Phe13 
and the uracil ring are preserved (Fig. 3G), the 
hydrogen bond network for the ribose moiety is 
completely abrogated (Fig. 3H). Even more, 
His54 is now ~90° flipped precluding CH/ 
interactions (Fig. 3I). These structural data 
provide an explanation for the observed truncated 
oligosaccharide chain in EPA-1 antigenic variant. 
 
Discussion 
Unlike the great majority of viruses, the 
chlorovirus PBCV-1 encodes most, if not all, of 
the machinery to glycosylate its MCP. In this 
study, the truncated glycan structures from a set 
of PBCV-1 antigenic variants were determined. 
These structures plus genetic evidence led to the 
identification of four GT activities encoded by 
three PBCV-1 genes: a064r, a071r and a075l, 
and enabled us to predict their functions. The 
a064r gene encodes a 638 amino acid protein 
with three domains: domain 1 is a putative -L-
rhamnosyltransferase, domain 2 is a previously 
unknown GT, here defined as probably being an 
-L-rhamnosyltransferase and domain 3 is a 
methyltransferase that decorates one or both 
positions of the terminal -L-Rha unit. Therefore, 
we predict that the A064R protein produces the 
disaccharide 2,3-diOMe--L-Rha-(1,2)--L-Rha 
attached to O-4 of the distal Xyl unit (Fig. 4). 
 Gene a071r is predicted to encode a GT 
that attaches a semiconserved -D-Rha to O-3 of 
the L-Fuc located in the N-glycan core region 
(Fig. 4). Gene a075r is predicted to encode the -
xylosyltransferase that attaches a D-Xyl unit to O-
4 of the same L-Fuc unit used as a substrate by 
A071R (Fig. 4). Finally, the putative GT(s) 
encoded by the a111/114r gene is predicted to be 
involved in the synthesis of four of the five 
residues composing the conserved glycan core 
structure (Fig. 4), because it is one of the few 
annotated GT encoding genes that is present in all 
the chloroviruses. However, it is not known if 
A111/114R transfers one or more of the sugars of 
the tetrasaccharide described in variant P1L6 
(Fig. 1). We cannot exclude the possibility that at 
least one or more other unknown PBCV-1 
encoded proteins besides A111/114R is involved 
in the assembly/attachment of the core glycan 
structure to the MCP. Alternatively, a host-
encoded enzyme(s) could also be involved in the 
synthesis/attachment of the glycan core structure. 
Viral encoded glycosylation is an 
emerging concept in virology, and it is not 
confined to virus PBCV-1. Other chloroviruses 
possess the genetic tools to accomplish this task 
and the same scenario probably occurs in other 
taxonomically unrelated viruses. Indeed, bovine 
herpesvirus and myxoma virus encode a -(1,6)-
GlcNAc- and a -(2,3)-sialyl-transferase, 
respectively (29). In addition, we predict that 
many of the giant viruses, characterized by large 
particle size and very large genomes (30), will 
encode at least some, if not all, of the enzymes 
needed to glycosylate their glycoproteins.  
The list of giant viruses includes all the 
known members of the Mimiviridae and 
Pandoraviridae families, along with Pithovirus 
and Mollivirus sibericum (30), and many others 
that are rapidly being discovered.  
The giant viruses mentioned above differ 
in morphology, genome size and physical size, 
but they share a common trait in that their 
genomes have several glycogenes, i.e., genes 
encoding enzymes able to manipulate sugar-
nucleotides and GTs. Past work has demonstrated 
that Mimivirus encodes three of the enzymes 
needed to synthetize UDP-GlcNAc (31), along 
with a functional pathway for UDP-Rha (32) and 
for UDP-N-Acetyl-viosamine production (33, 
34), and a functional glycogenin paralogue (35). 
For many of the giant viruses, except for the 
glycogenin of Mimivirus (35), the activities of the 
putative glycogenes are yet to be determined.  
If our prediction about giant viruses is 
correct, investigations of these organisms will 
provide the field of glycobiology with new 
discoveries and may ultimately answer the central 
question about what benefits these viruses have 
by maintaining their own glycosylation 
machinery through evolution.  
Finally, interest in the new GTs described 
in this report goes beyond the viral world, as they 
have similarities with prokaryotic and eukaryotic 
enzymes as exemplified by A064R-D1 for which 
the best matches are with LgtA, a prokaryotic 
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protein, and with a bovine -(1,3)-
galactosyltransferase (22). 
 
Experimental procedures 
Virus growth and glycopeptide isolation from 
major capsid proteins  
Antigenic variants of PBCV-1 (P9L10, 
P9L1, P91, EPA-1, EPA-2, E11, E1L3, P1L6 and 
CME6) were grown by infection of 4 L of 
Chlorella variabilis NC64A cells and purified as 
previously described (36) with some 
modifications: lysates were exposed to 1% Triton 
X-100 before two successive rounds of gradient 
centrifugation in 10-40% sucrose. The virus was 
treated with proteinase K (0.02 mg/ml) between 
the sucrose gradients to remove external 
contaminating proteins. The isolation of their 
MCPs followed an established protocol (16). 
Isolated amounts of MCP ranged from 0.2 mg to 
1.5 mg. To isolate the glycopeptides, the MCP 
from each variant was dissolved in water and 
digested with proteinase K (Sigma code P6556). 
The digestion process was conducted three times 
over a time interval of 36 hr using proteinase K at 
~20% by weight of the starting amount of the 
MCP. The glycopeptide mixture was purified via 
size exclusion chromatography as reported (11). 
Each antigenic variant produced one main 
glycopeptide fraction, eluting at approximately 
50% of the column volume, with the exception of 
virus E1L3, which produced two glycoforms. The 
less abundant form was about 5-10% of the total 
mixture; its proton spectrum was similar to that 
of the WT virus and it was not investigated 
further in this study. For the P1L6 virus variant, 
due to the low amount of the virus available, the 
purification step was omitted to avoid further 
losses. This glycopeptide was analysed directly 
via NMR spectroscopy; signals arising from the 
non-glycosylated peptides did not hinder the 
analysis of the glycan portion. 
 
Glycopeptide chemical analysis 
Partially methylated acetylated alditols, 
and fully acetylated alditols were generated from 
the purified glycoprotein (ca. 0.2 mg) or on the 
glycopeptides according to published protocols 
(37). Analyses of these derivatives was carried 
out via GC-MS on an Agilent Technologies Gas 
Chromatograph 6850A interfaced with a 
selective Mass Detector 5973N equipped with a 
SPB-5 capillary column (Supelco, 30 m x 0.25 
mm i.d., flow rate 0.8 mL min-1 using He as the 
carrier gas). Electron impact mass spectra were 
recorded with an ionization energy of 70 eV and 
an ionizing current of 0.2 mA. The following 
temperature program was used: 150°C for 5 min, 
3°C/min up to 300°C, 300°C for 5 min. 
 
NMR acquisition conditions 
All NMR experiments were carried out on 
a Bruker DRX-600 spectrometer equipped with a 
cryo-probe, calibrated with acetone used as an 
internal standard (H = 2.225 ppm; C = 31.45 
ppm) and recorded in D2O at 310 K (CME6, E11, 
EPA1, EPA2, P9L1, P9L10 and E1L6), or at 316 
K (P91) or at 323 K (E1L3) to shift the signal of 
the residual water peak in order to minimise its 
overlap with some of the glycopeptide signals. 
The complete set of two-dimensional spectra 
(DQ-COSY, TOCSY, T-ROESY, gHSQC and 
gHMBC) were recorded for all glycopeptides, 
except for PIL6, P9L1 and E11 for which the 
gHSQC experiment was enough to establish the 
structure of the glycan. The spectral width was set 
to 10 ppm and the frequency carrier placed at the 
residual HOD peak, suppressed by pre-saturation. 
Two-dimensional spectra were measured using 
standard Bruker software; for all the experiments, 
512 FIDs of 2048 complex data points were 
collected, 32 scans per FID were acquired for 
homonuclear spectra and mixing times of 100 and 
300 ms were used for TOCSY and T-ROESY 
spectra acquisition, respectively. Heteronuclear 
1H-13C spectra were measured in the 1H-detection 
mode, gHSQC spectrum was acquired with 30-60 
scans per FID (depending on the abundance of the 
sample), the GARP sequence was used for 13C 
decoupling during acquisition; gHMBC scans 
doubled those of gHSQC spectrum. 
 
Bioinformatics 
Geneious 11.0.5 software 
(https://www.geneious.com, 38) was used to 
deepen the genetic analysis of the variants to 
identify other genes involved in glycosylation or 
to define the nature of the mutation. The software 
was used to assemble and map antigenic mutant 
sequencing reads (total genome) to the PBCV-1 
WT reference genome. The software allowed for 
quick and easy identification of genetic variants 
in the antigenic mutant viruses. 
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MD simulation of UDP-Rha and UDP-Glc with 
domain 1 of A064R.  
The starting structure for MD simulation of 
the GT A064R D1 in complex with the substrate 
UDP-L-Rha was generated by replacing the Glc 
unit of the UDP-Glc with L-Rha in the complex 
with the enzyme (PDB code 2P72). The 
structures of the UDP-Rha and UDP-Glc were 
relaxed by energy minimization with a low 
gradient convergence threshold (0.05) in 1000 
steps with MM3* force field integrated in the 
MacroModel program run under Maestro 
(Schrödinger Release 2016-4, LLC, New York, 
NY, 2016). The nucleotide moiety of the 
minimized UDP-L-Rha and UDP-Glc were 
superimposed on the UDP molecule in the 
structure of A064R in complex with UDP (PDB 
code 2P73). Partial charges of the ligands were 
calculated using the Gaussian 09 package with 
HF/6-31G(d) basis set. All molecular parameters 
were converted using the Antechamber program 
in the Amber16 package. The resulting structures 
were used as starting points for molecular 
dynamics simulation of 100 ns in explicit water 
solvent, using the Amber16 program with the 
protein.ff14SB force field parameters for protein 
and the generalized amber force field gaff2 for 
the sugar-nucleotide, whereas water.tip3p force 
field was used for water and ions. The atomic 
parameters for Mn2+ ion were defined according 
to published data (39). The starting structures 
were solvated in a 10 Å octahedral box of explicit 
TIP3P waters, and counterions were added to 
maintain electroneutrality. In order to fill all of 
the protein cavities with water molecules, a 
previous minimization for only solvent and ions 
was made. To reach a low energy starting 
structure, the entire system was minimized with a 
higher number of cycles, using the accurate 
steepest descent algorithm. The system was 
subjected to two rapid molecular dynamic 
simulations (heating and equilibration) before 
starting the real dynamic simulation: i) 20 ps of 
MD heating the whole system from 0 to 300 K, 
using NVT (fixed number of atoms, N, a fixed 
volume, V, and a fixed temperature, T) ensemble 
and a cutoff of 10 Å, followed by ii) equilibration 
of the entire system over 100 ps at 300 K using 
NPT (fixed number of atoms, N, a fixed pressure, 
P, and a fixed temperature, T) ensemble and a 
cutoff of 10 Å. A relaxation time of 2 ps was used 
in order to equilibrate the entire system in each 
step. The equilibrated structure was the starting 
point for the final MD simulations at constant 
temperature (300 K) and pressure (1 atm). 
Molecular dynamics simulation without 
constraints was recorded, using an NPT ensemble 
with periodic boundary conditions, a cutoff of 10 
Å, and the particle mesh Ewald method. 
Coordinates and energy values were recorded 
every 10000 steps (20 ps) for a total simulation 
time of 100 ns and an ensemble of 5000 MD 
frames. A detailed analysis of the MD trajectory 
(for example, RMSD evaluation, kinetic and 
potential energies, etc.) was accomplished using 
the cpptraj module included in the Amber-Tools 
16 package, and it is gathered in the Supporting 
Information (Fig. S9). The structure of the GT 
from antigenic variant EPA-1, GT A064R 
D1_S79L mutant, in complex with the substrate 
UDP-L-Rha was generated by mutagenesis tool 
integrated in the PyMOL (The PyMOL 
Molecular Graphics System, Version 2.0 
Schrödinger, LLC) program. The generated 
structure was minimized using the Amber16 
program as previously described in this section.  
 
MM/GBSA calculations. 
Binding free energy analysis was 
performed by applying the MM/GBSA 
calculation. The molecular mechanic energies 
combined with the generalized Born and surface 
area continuum solvation method was applied to 
the structure of UDP-L-Rha and UDP-Glc, 
A064R-D1 and to the UDP-L-Rha/A064R-D1 
and UDP-Glc/A064R-D1 complexes generated 
from the MD simulations, as described in the 
previous section. The receptor-ligand complexes 
were energetically minimized by the MM/GBSA 
method as implemented in the Sander program of 
the Amber package. The atomic radii (set default 
PBRadii mbondi2) were chosen for all GBSA 
calculations. For the ensemble-average 
MM/GBSA rescoring, a MD trajectory was 
obtained for both UDP-L-Rha/- and UDP-
Glc/A064R-D1 complexes. Snapshots of the 
complex were extracted from the MD trajectory 
at every 10 ps. Thus, the final binding free energy 
is an average of the binding free energies of 
10000 snapshots.  
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molecular modeling; PBCV-1, Paramecium bursaria chlorella virus type 1; PMAA, partially methylated 
and acetylated alditols; SEC, size exclusion chromatography; TOCSY, total correlation spectroscopy; T-
ROESY, transverse rotating frame Overhauser effect spectroscopy; WT, wild-type 
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Table 1: Genetic features of the 20 PBCV-1 antigenic variants. These variants are divided into six classes 
depending on their reaction with polyclonal antibodies. Class E is not included in this study and omitted 
in this table, because the members of this group cross-react with the antibodies selective for both Classes 
A and B, suggesting an intermediate phenotype. All the antigenic classes, but C, have a mutation in 
a064r, this gene encodes for a protein of 638 amino acids that includes three domains of ca. 200 amino 
acids each (Fig. 1). The N-terminal domain 1 is a GT, domain 2 only matches bacterial proteins of 
unknown function, domain 3 has a weak match with methyltransferases. The structure of the N-glycans 
has been determined in this work (Fig. 1) for the antigenic variants typed in bold. 
Antigenic variant Antigenic Class A: mutation in the second domain of a064r (NP_048412.1) 
EPA-11 Nonsense mutation (G→A) at nt position 932 in the gene; truncated protein (307 amino 
acids) 
P9L1 Nonsense mutation (C→A) at nt position 704 in the gene; truncated protein (234 amino 
acids) 
P9L4 Missense mutation (G→T) at nt position 1102 in the gene; amino acid substitution 
(G368W) 
P9L7 Missense mutation (G→T) at nt position 1102 in the gene; amino acid substitution 
(G368W) 
P9L10 Nonsense mutation (T→G) at nt position 669 in the gene; truncated protein (222 amino 
acids) 
P91 Insertion of 27 nts after nt position 952 in the gene; insertion of 9 additional amino acids 
 Antigenic Class B: mutation in the first domain of a064r  (NP_048412.1) 
EPA-1 Missense mutation (C→T) at nt position 236 in the gene; amino acid substitution (S79L) 
EPA-2 Frameshift mutation; single nt insertion of A after position 262; truncated protein (88 + 11 
amino acids: frameshift results in 11 incorrect amino acids added before stop codon is 
encountered) 
P31 Missense mutation (G→A) at nt position 362in the gene; amino acid substitution (G121E) 
 Antigenic Class C: no mutation in a064r (except E11); mutation in a075l (NP_48423.1: 
280 amino acids) 
E11 Same mutation in a064r as EPA-1 (antigenic class B). Frameshift mutation in a075l; single 
nucleotide addition at position 670; truncated protein (223 + 16 amino acids; frameshift 
results in 16 incorrect amino acids added before premature stop codon is encountered).  
E1L1 Frameshift mutation; single nt deletion at position 666 in the gene; truncated protein (222 
amino acids) 
E1L2 Nonsense mutation (G→A) at nt position 630 in the gene; truncated protein (209 amino 
acids) 
E1L3 Missense mutation (A→T) in the initiator codon at nt position 1 in the gene; no protein 
synthesis 
E1L4 Nonsense mutation (T→A) at nt position 659 in the gene; amino acid substitution (I220N) 
P41 Frameshift mutation single nt insertion of C after position 194 in the gene; truncated protein 
(65 + 14 amino acids: frameshift results in 14 incorrect amino acids added before stop 
codon is encountered) 
 Antigenic Class D: a064r fully deleted 
P1L2 Large deletion of 27,160 nts between genomic positions 12,320 and 39,480; the deletion 
includes the 44 nts at the 3’ region of gene a014r through and including approximately half 
of gene a075l. 
P1L3 Large deletion of 37,450 nts between genomic positions 4,970 and 42,420; the deletion 
includes gene a009r through gene a078r (the 5’ breakpoint is between genes a007/008l and 
a009r while the 3’ breakpoint is between genes a078r and a079r). 
P1L6 Large deletion of 38,642 nts between genomic positions 2,168 and 40,810; the deletion 
includes the terminal one-sixth of gene a003r through the middle of gene a077l. 
P1L10 Large deletion of 32,060 nts between genomic positions 7,700 and 39,760; the deletion 
includes approximately 60% of gene a011l through two-thirds of gene a075l. 
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 Antigenic Class F: mutation in the third domain of a064r (NP_048412.1) 
CME6 Frameshift mutation; insertion of 2 nts at position 1320 in the gene; truncated protein (440 
+ 10 amino acids: frameshift results in 10 incorrect amino acids added before stop codon 
encountered) 
 
Table 2. Calculated binding free energies (kcal/mol) for UDP-Rha  (UDP-Rha) and UDP-Glc (UDP-Glc) 
to A064R-D1. The binding free energy (Gbind) is decomposed into different energy terms: the gas-phase 
interaction energy (∆Egas) between the receptor and the ligand is the sum of electrostatic (∆EELE) and van 
der Waals (∆EVDW) interaction energies. The solvation free energy (∆Gsol) is divided into the polar (∆GGB) 
and non-polar (∆GSurf) energy terms.  
 
Substrate EELE EVDW Egas GSurf GGB GSol Gbind 
UDP-Rha -200.21 -26.13 -226.35 -6.17 152.90 146.73 -79.63 
UDP-Glc -230.84 -24.86 -255.71 -7.11 188.85 181.74 -73.97 
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Fig. 1. Glycan structures of WT and selected antigenic mutants of PBCV-1. In the WT, each 
monosaccharide is denoted with the letter used during the NMR experiments, and residues inside the dotted 
box define the conserved core region. The glycosidic linkage of non-stoichiometric substituents is denoted 
with a broken line. Glyco1 and glyco2 are the most abundant glycoforms, both have Man. Glyco1 lacks 
Ara and the units of the terminal L-Rha disaccharide are labelled as C and I. Ara is present in glyco2 and 
the two L-Rha units are labelled B and L. Antigenic classes are labeled with a capital letter, (A-D and F) 
and the structure of their glycans depends on the kind of mutation found in the genome, which in all cases, 
except Classes C and D, occurs in the gene a064r. EPA1 (antigenic Class B) and E11 (antigenic Class C) 
have identical mutations in domain 1 of a064r, but E11 has an additional mutation in gene a075l. P91 has 
an additional glycoform with -L-Rha methylated at O-2, the letters used to label this oligosaccharide are 
not reported due to crowding, and the structure is displayed in Fig. S7. 
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Fig. 2. Anomeric region of the proton spectra of different variants, each representative of its antigenic class 
(A-D and F). The proton spectrum of the WT virus PBCV-1 is given for comparison [with permission from 
De Castro et al. (11)]. NMR spectra were recorded at 310 K except for P91 (316 K) and E1L3 (323 K). 
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Fig. 3. Comparison of the active sites from the X-ray crystal structure of A064R-D1_WT:UDP-Glc (A-C), 
a representative frame from MD simulation of A064R-D1_WT:UDP-L-Rha (D-F) and a minimized 
structure of the mutant A064R-D1_S79L:UDP-L-Rha (G-I). (A,B,D,E) The binding mode of UDP is 
essentially the same in either UDP-Glc crystal structure or UDP-L-Rha MD simulated structure. (C) and 
(F): as expected, a different intermolecular interaction network is observed. For UDP-L-Rha, the His54 
moves towards the Rha ring establishing CH- interactions with the sugar (green dotted lines). (G-I) The 
mutation of the Ser79 by Leu dramatically alters substrate binding. Most of the intermolecular interactions 
are abrogated. Hydrogen bonds are highlighted with red dotted lines, -stacking (in F) are highlighted with 
green dotted lines. UDP-Glc, UDP-L-Rha, and key residues of the enzyme are shown as blue, red-purple, 
and green sticks, respectively. Manganese is represented as purple sphere.  
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Fig. 4. PBCV-1 glycan structure with the predicted GTs involved in the glycosidic bond formation. The 
CAZY family fold is indicated in brackets next to the gene name (unk = unknown function, predicted as 
GT in this study; nc: unclassified GT fold). Based on the data available, a111/114r is involved in the 
formation of the tetrasaccharide enclosed in the inner grey box. Currently it is unknown if it catalyzes the 
formation of one or more of the four glycosidic linkages enclosed. The larger grey box indicates the 
monosaccharide units of the conserved N-glycan core region that is common to all other chloroviruses 
examined to date. D1-, D2- and D3- refer to the three domains of protein A064R. Linkages for which the 
corresponding GT is not identified yet are the non-stoichiometric substituents, Man and Ara, and have a 
“?” next to them. 
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Class A: structure of the glycans of the antigenic variants P91, P9L1 and P9L10  
The glycopeptides from the three class A variants had a similar pattern of signals in the 
anomeric region of the 1H NMR spectra, although some variations in their relative intensities were 
observed (Fig. S5A). The resonances at ca. 5.2 ppm included two different protons in a ratio 1:2 in 
P9L10 and P91 while 1:1 in P9L1; the resonances at  5.05 ppm included three signals in P9L10 and 
P9L1 and only two in P91. This type of heterogeneity suggested that these viruses produced a mixture 
of glycopeptides with one or more substituents present in non-stoichiometric amounts, as described 
for the Man and Ara units in the N-glycans of the wild-type virus PBCV-1. The most abundant 
sample, P9L10, was studied first and the structural information derived was used to interpret the 
spectra of the glycopeptides from the other two variants. 
Comparison of P9L10 HSQC spectrum with that of PBCV-1 readily identified a set of 
equivalent residues, namely: A, D, E, F, G, N and H (Fig. 1, Fig. S5B); therefore, our analyses 
focused on the remaining signals. In particular, the resonance at 5.03 ppm was analogous to F’ 
described for the antigenic classes B and C; thus, it was an un-substituted D-Rha. In the HMBC 
spectrum, the F’ unit had a correlation with a signal at 1H/13C 4.23/87.4 ppm, identified as position 
three of A’, a Fuc unit substituted at all positions available and with Gal unit E’ at O-2. Analysis of 
the anomeric proton resonance at 4.46 ppm (Fig. S6), diagnostic of the distal Xyl unit, showed a 
correlation with two different equatorial H-5 signals, at 4.34 and 4.25 ppm, suggesting that this signal 
was a combination of two anomeric protons, labelled M and M”. Compared to M, proton and carbon 
chemical shifts of M” were similar except for the equatorial H-5 and C-4 that in M” were at 4.25 and 
79.7 ppm instead of 4.34 and 80.8 ppm, respectively. We assumed that the difference between M and 
M” depended on the non-stoichiometric substitution of D-rhamnose with Man, and that M” was the 
distal xylose unit the glycan devoid of Man residue (structures P9L10B and P9L10C in Fig. S6). The 
region at 4.8-4.7 ppm contained four anomeric signals, all attributed to -L-Rha units (Figs. S5, S6), 
which were labeled as I, I’, L and L’ (Table S5). The anomeric protons of I and I’ were at 4.73 and 
4.79 ppm, respectively (Fig. S6), and both correlated with a H-2/C-2 at 4.06 (or 4.07)/72.0 ppm. 
Analysis of the TOCSY spectrum from each H-2, determined the position of all the other protons of 
the two units. The 1H and 13C values of these two units (Table S5) disclosed that they were not 
glycosylated while the HMBC spectrum indicated that I was linked to O-4 of M while I’ to O-4 of 
M”.  
As for L and L’, H-2/C-2 and H-3/C-3 were found at 4.24 (or 4.23)/69.3 and 3.71/80.0 ppm, 
respectively. These chemical shift values indicated that both units had a substituent at O-3, due to the 
-glycosylation effect, which displaces C-3 to low fields with respect to the reference value (Bock & 
Pedersen, 1983). L and L’ were linked to M and M”, respectively and both had an Ara unit D at O-
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3, but unlike the PBCV-1 glycan, they were not elongated further with an -Rha unit. Indeed, P9L10 
produces a family of four glycopeptides, named P9L10A-D (Fig. S6), differing in the non-
stoichiometric presence of two residues, Man and Ara, as shown in Fig. S6. 
As for the P9L1 glycopeptides, the amount recovered after purification was low but enough to 
record and compare the HSQC spectrum with that of P9L10. Their two spectra were very similar and 
contained the same densities, with some variations occurring in their intensities as deduced by 
comparing their proton spectra (Fig S5). Indeed, in P9L1 the intensities of E and E’ were comparable 
suggesting that D-Rha was much less substituted with Man compared to P9L10 glycopeptides. 
Densities reporting the Ara unit were not detected in the HSQC spectrum, indicating that this unit 
was absent or below the instrumental detection limit. Accordingly, P9L1 produced two main 
glycopeptides, analogues to P9L10A and P9L10B (Fig. S6). 
The same strategy was applied to the glycopeptides of the P91 variant. Most of the densities of 
its HSQC spectrum (Fig. S7A, B) overlapped with those of the P9L1 variant. Thus, the P91 variant 
produced two oligosaccharides equivalent to P9L10A and P9L10B, as confirmed by analyzing the 
homonuclear spectra (T-ROESY in Fig. S7C and TOCSY in Fig. S7D). Importantly, these spectra 
enabled the assignment of densities that escaped the HSQC detection due to the low amount of the 
sample, including C-4 or C-5 of M” (the putative position of these densities is enclosed in a dotted 
circle in Fig. S7B). 
The P91 HSQC spectrum contained some additional signals, a methyl group at 1H/13C 3.56/62.4 
ppm (Fig. S7A) and a new anomeric proton at 1H/13C 4.75/103.4 ppm (Fig. S7B). NMR analysis of 
the new residue determined that it was a -L-Rha, labelled as I”, that differed from I and I’ because 
it was methylated at O-2 (Table S6); methylation at O-2 did not induce relevant variations in the 
chemical shift values of all the other monosaccharides of the glycan, except for H-4/C-4 values of the 
Xyl unit to which it was attached, named M’”, at 1H/13C 3.71/80.5 ppm instead of 3.75/80.8 ppm, as 
in M of P9L10A or at 3.77/79.7 ppm as in M” of P9L10B. For this new oligosaccharide (named P91, 
Fig. S7) it was not possible to confirm if the D-Rha unit F was further elongated with Man G, although 
this situation is the most plausible because elongation with Man seems to be a dominant trait in this 
variant of PBCV-1. 
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Table S1.  Features of putative glycosyltransferases of PBCV-1.  
Putative GT Accession no. Size1 Location2 TM3 CAZy family4 
A064R NP_048412 638 Cytoplasm None GTnc5 
A071R6 NP_048419.1 354 Cytoplasm None Unknown 
A075L NP_048423.1 280 Cytoplasm None GT47 
A098R NP_048446.1 568 Plastid 7 GT2 
A111/114R NP_048459.2 860 Cytoplasm None GT2 
A219/222/226R NP_048569.3 677 Plastid 9-10 GT2 
A473L NP_048829.1 517 Plastid 6 GT2 
A546L NP_048902.4 396 Cytoplasm None GTB 
1Number of amino acids 
2Cellular localization determined using WoLF PSORT Prediction: 
https://www.genscript.com/tools/wolf-psort 
3Number of transmembrane helice predicted using TMHMM v.2.0:  
http://www.cbs.dtu.dk/services/TMHMM/ 
4CAZy Carbohydrate Active Enzyme website:  www.cazy.org 
5GTnc = glycosyltransferase family “not classified” 
6Determined in this work. 
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Table S2. 1H and 13C chemical shifts of glycopeptide from P1L6, the antigenic variant of Class D. Labels 
used reflect those originally used for the glycan of the wild type virus PBCV-1. For structure, refer to figure 
S1. 
 
  1 2 3 4 5 (5eq;5ax) 6;6’ 
A 1H 5.61 3.94 4.16 3.78 4.73 1.20 
2--L-Fuc 13C 98.7 75.2 70.5 73.7 67.6 16.6 
D 1H 5.28 3.84 3.90 4.02 4.05 3.73 x 2 
t--D-Gal 13C 101.3 70.1 70.7 70.5 72.7 62.5 
H 1H 4.97 3.58 3.92 3.75 3.64 3.96;3.89 
3,4-D--Glc 13C 80.8 75.0 77.3 74.7 78.2 60.1 
N 1H 4.42 3.15 3.44 3.49 3.93;3.26 -- 
t--D-Xyl 13C 103.8 75.0 76.9 70.9 66.2 -- 
 
 
Table S3. Proton and carbon chemical shifts obtained for E1L3 or E11 glycopeptides (class C antigenic 
class). For structure, refer to figure S2 or S3. 
 
  1 2 3 4 5 (5eq;5ax) 6;6’ 
A 1H 5.64 4.09 4.24 3.79 4.76 1.23 
2,3--L-Fuc 13C 98.5 71.9 79.6 73.7 67.6 16.2 
E 1H 5.23 3.85 3.90 4.06 4.06 3.75 x 2 
t--D-Gal 13C 100.6 69.7 70.9 70.4 72.4 62.2 
F’ 1H 5.01 4.11 3.87 3.50 3.82 1.32 
t--D-Rha 13C 104.4 71.4 71.6 73.3 70.1 18.0 
H 1H 5.03 3.61 3.96 3.75 3.67 3.96;3.85 
3,4-D--Glc 13C 80.7 75.0 76.7 74.9 78.1 60.7 
N 1H 4.46 3.18 3.48 3.60 3.99;3.30 -- 
t--D-Xyl 13C 103.9 75.0 76.9 70.9 66.1 -- 
 
 
 
Table S4. Proton and carbon chemical shifts obtained for EPA1 or EPA2 glycopeptides (class B antigenic 
class). For structure, refer to figure S4. 
  1 2 3 4 5 (5eq;5ax) 6;6’ 
A 1H 5.63 4.18 4.22 3.86 4.75 1.31 
2,3,4--L-Fuc 13C 98.6 72.0 77.0 82.5 68.5 16.2 
E 1H 5.23 3.82 3.86 4.03 4.03 3.74;3.71 
t--D-Gal 13C 100.2 69.6 71.0 70.4 72.5 62.3 
F’ 1H 5.04 4.04 3.75 3.50 4.10 1.30 
t--D-Rha 13C 104.0 71.5 71.5 73.3 70.1 17.9 
H 1H 5.01 3.58 3.95 3.72 3.66 3.94;3.83 
3,4-D--Glc 13C 80.4 75.0 76.8 74.9 78.1 60.6 
M’ 1H 4.46 3.39 3.45 3.66 4.03;3.23 -- 
t--D-Xyl 13C 105.6 74.9 77.0 70.6 66.1 -- 
N 1H 4.42 3.14 3.45 3.59 4.03;3.27 -- 
t--D-Xyl 13C 104.1 74.9 77.0 71.0 66.1 -- 
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Table S5. Proton and carbon chemical shifts obtained for the four P9L10 glycopeptides from antigenic class 
A (structures reported in Fig. S6). 
  1 2 3 4 5 (5eq;5ax) 6;6’ 
A 1H 5.62 4.18 4.20 3.87 4.76 1.30 
2,3,4--L-Fuc 13C 98.6 72.0 76.3 82.3 68.5 16.3 
A’ 1H 5.64 4.16 4.23 3.87 4.76 1.30 
2,3,4--L-Fuc 13C 98.6 72.0 77.4 82.3 68.5 16.3 
D 1H 5.19 4.19 4.20 3.92 3.79;3.70 -- 
t--L-Araf 13C 100.3 77.6 74.6 83.1 62.9 -- 
E 1H 5.19 3.79 3.84 4.02 4.03 3.71 x 2 
t--D-Gal 13C 100.1 69.7 71.1 70.6 72.3 62.7 
E’ 1H 5.23 3.83 3.85 4.02 4.03 3.71 x 2 
t--D-Gal 13C 100.3 69.7 71.1 70.6 72.7 62.7 
F 1H 5.06 4.19 3.87 3.58 4.11 1.30 
3--D-Rha 13C 103.5 71.4 79.8 72.4 70.5 18.2 
F’ 1H 5.03 4.04 3.75 3.48 4.14 1.28 
t--D-Rha 13C 104.2 71.6 71.7 73.2 70.2 18.2 
G 1H 5.05 4.08 3.87 3.59 3.81 3.91;3.71 
t--D-Man 13C 104.2 71.5 72.1 68.5 75.1 62.9 
H* 1H 4.97 3.58 3.96 3.71 3.65 3.94;3.83 
3,4--D-Glc 13C 80.8 75.2 77.0 75.0 78.2 60.7 
I 1H 4.73 4.07 3.59 3.35 3.43 1.30 
t--L-Rha 13C 102.6 72.0 73.9 73.4 73.2 18.5 
I’ 1H 4.79 4.06 3.59 3.35 3.38 1.30 
t--L-Rha 13C 102.1 72.0 73.9 73.3 73.2 18.5 
L 1H 4.74 4.24 3.71 3.45 3.43 1.32 
3--L-Rha 13C 102.6 69.3 80.0 71.7 73.2 18.6 
L’ 1H 4.80 4.23 3.71 3.45 3.45 1.32 
3--L-Rha 13C 102.1 69.3 80.0 71.7 73.2 18.6 
M 1H 4.46 3.43 3.58 3.75 4.34;3.28 -- 
4--D-Xyl 13C 105.4 74.8 75.7 80.8 65.7 -- 
M” 1H 4.46 3.43 3.58 3.77 4.25;3.28 -- 
4--D-Xyl 13C 105.4 74.8 75.7 79.7 65.4 -- 
N 1H 4.42 3.15 3.45 3.59 4.03;3.28 -- 
t--D-Xyl 13C 104.1 75.0 77.2 71.1 66.2 -- 
* N-linked Glc appeared as a group of two different anomeric signals at 4.97 and 5.02 ppm, probably due to the heterogeneity in the 
peptide portion. Chemical shifts of the most abundant residue, H, are listed in the table; H’ differed from H only for the chemical 
shift of the anomeric proton. 
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Table S6. Proton and carbon chemical shifts obtained for the glycopeptides of P91 variants (antigenic class 
A). For simplicity, chemical shift values of the two glycans P9L10A and P9L10B are not repeated and listed 
in Table S4, while this table reports the only values of the new units, I” and M’” (structure named as P91 is 
reported in Fig. S7). 1H and 13C chemical shifts of the methyl group are 3.56 and 62.4 ppm, respectively. For 
structure, refer to figure S7. 
  1 2 3 4 5 (5eq;5ax) 6 
I” 1H 4.75 3.78 3.59 3.27 3.40 1.30 
t-2OMe--L-Rha 13C 103.4 81.7 73.9 73.6 73.2 18.5 
M”’ 1H 4.46 3.43 3.58 3.71 4.34;3.28 -- 
4--D-Xyl 13C 105.4 74.8 75.7 80.5 65.7 -- 
 
 
 
 
 
 
 
Table S7. Proton and carbon chemical shifts obtained for the two CME6 glycopeptides (structures reported 
in Fig. S8).  
 
  1 2 3 4 5 (5eq;5ax) 6;6’ 
A 1H 5.62 4.17 4.21 3.88 4.74 1.30 
2,3,4--L-Fuc 13C 98.6 72.0 76.2 82.0 68.5 16.3 
B 1H 5.15 4.05 3.86 3.43 4.10 1.26 
t--L-Rha 13C 101.8 71.4 71.3 73.4 4.10 17.8 
C 1H 5.04 4.09 3.86 3.43 4.10 1.26 
t--L-Rha 13C 102.7 72.3 71.3 73.4 69.9 17.8 
D 1H 5.19 4.20 4.20 3.91 3.78;3.71 -- 
t--L-Araf 13C 100.1 77.4 74.1 83.0 62.8 -- 
E 1H 5.19 3.78 3.83 4.00 4.02 3.71 x 2 
t--D-Gal 13C 100.1 69.7 71.2 70.6 72.6 62.6 
F 1H 5.05 4.18 3.86 3.56 4.12 1.30 
3--D-Rha 13C 103.6 71.4 80.0 72.3 70.5 18.2 
G 1H 5.04 4.08 3.86 3.60 3.81 3.91;3.71 
t--D-Man 13C 104.2 71.5 72.1 68.5 75.1 62.9 
H 1H 4.96 3.57 3.95 3.70 3.65 3.93;3.83 
3,4--D-Glc 13C 80.8 75.1 77.0 74.9 78.2 60.7 
I 1H 4.78 4.14 3.70 3.38 3.47 1.30 
2--L-Rha 13C 102.6 78.1 74.6 73.4 73.6 18.5 
L 1H 4.77 4.31 3.74 3.47 3.49 1.32 
2,3--L-Rha 13C 102.6 74.4 80.4 72.4 73.5 18.6 
M 1H 4.44 3.43 3.55 3.74 4.33;3.25 -- 
4--D-Xyl 13C 105.3 75.0 75.9 81.0 65.8 -- 
N 1H 4.41 3.14 3.44 3.59 4.03;3.27 -- 
t--D-Xyl 13C 104.1 74.9 77.2 71.1 66.2 -- 
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Supporting figures. 
 
 
 
 
 
Fig. S1. Expansion of HSQC spectrum measured at 310 K for P1L6 glycopeptide (antigenic class D). Densities 
are labeled with a letter in analogy with that used for PBCV-1 glycans (Fig. 1). 
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Fig. S2. Collection of experimental data acquired for class C variants. A) Comparison of the anomeric region 
of the proton spectra of E1L3 and E11 variants. B) Expansion of HSQC spectrum measured at 310 K for E1L3 
glycopeptide. Densities are labeled with a letter in analogy with that used for PBCV-1 glycans (Fig. 1). C) GC-
MS chromatograms of the monosaccharide linkage analysis of E1L3; E11 gave equivalent results. *Impurities. 
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Fig. S3. Expansion of HSQC spectrum measured at 310 K for E11 glycopeptide (antigenic class C). Densities 
are labeled with a letter in analogy with that used for PBCV-1 glycans (Fig. 1). 
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Fig. S4. Collection of experimental data acquired for class B. A) Comparison of the anomeric region of the 
proton spectra of EPA1 and EPA2 variants. B) Expansion of HSQC spectrum measured at 310 K for EPA2 
glycopeptide. Densities are labeled with a letter in analogy with that used for PBCV-1 glycans (Fig. 1). 
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Fig. S5. Collection of experimental data acquired for class A. A) Comparison of the anomeric region of the 
proton spectra of P9L10, P9L1, and P91 variants. B) Expansion of HSQC spectrum measured at 310 K for 
P9L10 glycopeptide, equivalent to that of P9L1, which is therefore omitted. Densities are labeled with a letter 
in analogy with that used for PBCV-1 glycans (Fig. 1). C) GC-MS chromatograms of the monosaccharide 
composition as acetylated alditols of P91. Chemical analysis of the other two antigenic variants gave the same 
results except for the 2O-Me-Rha unit that was missing. * Impurities. 
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Fig. S6. Expansion of TOCSY (black) and COSY (cyan/red) spectra detailing the anomeric region of P9L10 
glycopeptide mixture. P9L10 produces a mixture of four different glycopeptides, sketched on the top of the 
figure, and that differ for the nonstoichiometric presence of Man G and Ara D, as occurs in PBCV-1 N-glycans. 
This heterogeneity in substitution induces the splitting of many signals, as for the -Rha unit for which four 
different anomeric signals exist (I, I’, L and L’). Notably, for -Rha, the H-1/H-2 correlation is too weak to 
be detected in the COSY spectrum, while it is visible in the TOCSY, and two vertical dotted gray lines are 
added to indicate that the densities I1,2 and L1,2 (or I’1,2 and L’1,2) do not align. P9L1 produces a mixture of 
glycopeptides constituted from P9L10A and P9L10B species.  
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Fig. S7. Collection of NMR data acquired for class A variant P91. A,B) expansions of HSQC spectrum 
detailing the hydroxymethyl and carbinolic regions, respectively. Of note, the oligosaccharide P91 produces 
only small amounts of P9L10B glycan therefore some of the correlations are missing, as occurs for H-4/C-4 
M’’ and H-5/C-5 of M’’ densities, whose putative position is indicated with a dotted circle. C) T-ROESY 
spectrum region detailing the correlations of the -Rha units, with that connecting H-1 of I’ pointing to H-4 of 
M’’. D) TOCSY spectrum region detailing the complex pattern of the distal Xyl units M, M’’ and M’’’. 
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Fig. S8. Expansion of HSQC spectrum measured at 310 K for CME6 glycopeptide (antigenic class F). 
Densities are labeled with a letter in analogy with that used for PBCV-1 glycans (Fig. 1). 
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Fig. S9. Distance evolution among the atoms involved in intermolecular interactions of A064R-D1: UDP-Rha 
as function of simulation time. 
 
 
